Major depressive disorder (MDD) is possibly a long haul or even deep rooted ailment for some patients, and upkeep treatment is intended to anticipate backslide in patients with intermittent wretchedness who have accomplished reduction. Patients who have leftover indications, progressing psychosocial stressors, or comorbid diseases are among the appropriate contender for upkeep treatment. In the accompanying discourse, specialists in the treatment of gloom deliver themes significant to support treatment: length of treatment, pharmacotherapy measurement, psychotherapy, and electro-convulsive treatment (ECT). Recommendations are likewise offered for enhancing subthreshold depressive side effects and treatment adherence.
Dr. Dunner: We will examine a few issues that emerge while treating MDD over the long haul and endeavoring to anticipate repetitive sorrow. Give us a chance to start by discussing the distinction between continuation treatment and support treatment.
Dr. Keller: Continuation treatment is planned to avert backslide, that is, to smother the manifestations of a present depressive scene from which the patient has not completely recouped (Figure 1).1 Usually, continuation treatment endures 4 to a half year after a patient has reacted in the intense period of treatment